name,category,termsNDRG family member 4,INTERPRO[450003654$IPR004142:Ndr]
NDRG family member 4,PIR_SUPERFAMILY[630019009$PIRSF023830:Caenorhabditis elegans hypothetical protein ZK1073.1]
NDRG family member 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790001162$phosphoprotein]
NDRG family member 4,UP_SEQ_FEATURE[850047002$chain:Protein NDRG4, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850118574$splice variant]
calcium channel, voltage-dependent, T type, alpha 1G subunit,INTERPRO[450001840$IPR002077:Voltage-dependent calcium channel, alpha-1 subunit, 450004904$IPR005445:Voltage-dependent calcium channel, T-type, alpha-1 subunit, 450005268$IPR005821:Ion transport]
calcium channel, voltage-dependent, T type, alpha 1G subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038887$hsa04930:Type II diabetes mellitus]
calcium channel, voltage-dependent, T type, alpha 1G subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001304$repeat, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, T type, alpha 1G subunit,UP_SEQ_FEATURE[850100543$chain:Voltage-dependent T-type calcium channel subunit alpha-1G, 850102573$compositionally biased region:Poly-Gly, 850102574$compositionally biased region:Poly-His, 850105770$glycosylation site:N-linked (GlcNAc...), 850116205$repeat:I, 850116211$repeat:II, 850116226$repeat:III, 850116236$repeat:IV, 850117294$sequence conflict, 850117960$site:Calcium ion selectivity and permeability, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 14 open reading frame 180,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 14 open reading frame 180,UP_SEQ_FEATURE[850066257$chain:Transmembrane protein C14orf180, 850118623$transmembrane region]
egl nine homolog 2 (C. elegans),INTERPRO[450004592$IPR005123:Oxoglutarate and iron-dependent oxygenase, 450006039$IPR006620:Prolyl 4-hydroxylase, alpha subunit]
egl nine homolog 2 (C. elegans),KEGG_PATHWAY[470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma]
egl nine homolog 2 (C. elegans),SMART[760000609$SM00702:P4Hc]
egl nine homolog 2 (C. elegans),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000437$dioxygenase, 790000802$iron, 790000937$metal-binding, 790001065$nucleus, 790001092$oxidoreductase, 790001626$vitamin c]
egl nine homolog 2 (C. elegans),UP_SEQ_FEATURE[850000176$binding site:2-oxoglutarate, 850017011$chain:Egl nine homolog 2, 850103759$domain:Fe2OG dioxygenase, 850106003$metal ion-binding site:Iron, 850106259$mutagenesis site, 850117294$sequence conflict]
histone cluster 1, H1c,INTERPRO[450005266$IPR005818:Histone H1/H5, 450005267$IPR005819:Histone H5, 450010816$IPR011991:Winged helix repressor DNA-binding]
histone cluster 1, H1c,PIR_SUPERFAMILY[630029831$PIRSF038219:histone H1]
histone cluster 1, H1c,SMART[760000466$SM00526:H15]
histone cluster 1, H1c,SP_PIR_KEYWORDS[790000011$acetylated amino end, 790000012$acetylation, 790000315$chromosomal protein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000466$dna-binding, 790000811$isopeptide bond, 790000953$methylation, 790001057$nucleosome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
histone cluster 1, H1c,UP_SEQ_FEATURE[850023953$chain:Histone H1.2, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850117295$sequence variant]
interleukin 18 receptor 1,BIOCARTA[30000150$h_IL12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development, 30000203$h_nktPathway:Selective expression of chemokine receptors during T-cell polarization, 30000294$h_th1th2Pathway:Th1/Th2 Differentiation]
interleukin 18 receptor 1,INTERPRO[450000133$IPR000157:Toll-Interleukin receptor, 450003160$IPR003599:Immunoglobulin subtype, 450003590$IPR004074:Interleukin-1 receptor, type I and type II, 450003591$IPR004075:Interleukin-1 receptor, type I/Toll precursor, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold, 450014058$IPR015621:Interleukin-1 receptor]
interleukin 18 receptor 1,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction]
interleukin 18 receptor 1,OMIM_DISEASE[520003637$Newly identified genetic risk variants for celiac disease related to the immune response]
interleukin 18 receptor 1,SMART[760000227$SM00255:TIR, 760000357$SM00409:IG]
interleukin 18 receptor 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
interleukin 18 receptor 1,UP_SEQ_FEATURE[850026546$chain:Interleukin-18 receptor 1, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850105529$domain:TIR, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
methyltransferase 10 domain containing,INTERPRO[450009355$IPR010286:S-adenosyl-L-methionine dependent methyltransferase, predicted, 450015502$IPR017182:S-adenosyl-L-methionine dependent methyltransferase, Mett10D, predicted]
methyltransferase 10 domain containing,PIR_SUPERFAMILY[630028901$PIRSF037350:Mtase_ZK1128_prd, 630028902$PIRSF037350:S-adenosyl-L-methionine dependent methyltransferase, ZK1128.2 type]
methyltransferase 10 domain containing,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000954$methyltransferase, 790001162$phosphoprotein, 790001212$polymorphism, 790001348$s-adenosyl-l-methionine, 790001547$transferase]
methyltransferase 10 domain containing,UP_SEQ_FEATURE[850000532$binding site:S-adenosyl-L-methionine, 850000543$binding site:S-adenosyl-L-methionine; via carbonyl oxygen, 850052691$chain:Putative methyltransferase METT10D, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
mucin 17, cell surface associated,INTERPRO[450000068$IPR000082:SEA, 450000637$IPR000742:EGF-like, type 3, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site]
mucin 17, cell surface associated,SMART[760000155$SM00181:EGF, 760000173$SM00200:SEA]
mucin 17, cell surface associated,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
mucin 17, cell surface associated,UP_SEQ_FEATURE[850032650$chain:Mucin-17, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850102883$disulfide bond, 850103596$domain:EGF-like, 850105275$domain:SEA, 850105770$glycosylation site:N-linked (GlcNAc...), 850110556$region of interest:59 X approximate tandem repeats, 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115245$repeat:18, 850115257$repeat:19, 850115273$repeat:2, 850115331$repeat:20, 850115343$repeat:21, 850115355$repeat:22, 850115367$repeat:23, 850115380$repeat:24, 850115392$repeat:25, 850115404$repeat:26, 850115408$repeat:27, 850115410$repeat:28, 850115412$repeat:29, 850115417$repeat:3, 850115444$repeat:30, 850115445$repeat:31, 850115447$repeat:32, 850115449$repeat:33, 850115451$repeat:34, 850115453$repeat:35, 850115455$repeat:36, 850115457$repeat:37, 850115459$repeat:38, 850115461$repeat:39, 850115467$repeat:4, 850115483$repeat:40, 850115485$repeat:41, 850115487$repeat:42, 850115492$repeat:43, 850115494$repeat:44, 850115495$repeat:45, 850115497$repeat:46, 850115499$repeat:47, 850115501$repeat:48, 850115503$repeat:49, 850115506$repeat:5, 850115510$repeat:50, 850115512$repeat:51, 850115514$repeat:52, 850115516$repeat:53, 850115518$repeat:54, 850115520$repeat:55, 850115522$repeat:56, 850115524$repeat:57, 850115526$repeat:58, 850115530$repeat:59, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117295$sequence variant, 850117814$signal peptide, 850117969$site:Cleavage, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
nuclear receptor subfamily 1, group H, member 3,BIOCARTA[30000118$h_fxrPathway:FXR and LXR Regulation of Cholesterol Metabolism, 30000211$h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity, 30000235$h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)]
nuclear receptor subfamily 1, group H, member 3,INTERPRO[450000459$IPR000536:Nuclear hormone receptor, ligand-binding, core, 450000806$IPR000923:Blue (type 1) copper domain, 450001442$IPR001628:Zinc finger, nuclear hormone receptor-type, 450001527$IPR001723:Steroid hormone receptor, 450001531$IPR001728:Thyroid hormone receptor, 450006475$IPR007087:Zinc finger, C2H2-type, 450008168$IPR008946:Nuclear hormone receptor, ligand-binding, 450011732$IPR013088:Zinc finger, NHR/GATA-type]
nuclear receptor subfamily 1, group H, member 3,KEGG_PATHWAY[470038821$hsa03320:PPAR signaling pathway]
nuclear receptor subfamily 1, group H, member 3,OMIM_DISEASE[520001995$Genome-wide association analysis of metabolic traits in a birth cohort from a founder population]
nuclear receptor subfamily 1, group H, member 3,SMART[760000350$SM00399:ZnF_C4, 760000376$SM00430:HOLI]
nuclear receptor subfamily 1, group H, member 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001301$receptor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
nuclear receptor subfamily 1, group H, member 3,UP_SEQ_FEATURE[850036544$chain:Oxysterols receptor LXR-alpha, 850102946$DNA-binding region:Nuclear receptor, 850105852$helix, 850113269$region of interest:Ligand-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118866$zinc finger region:NR C4-type]
nucleoporin 155kDa,INTERPRO[450004344$IPR004870:Nucleoporin, non-repetitive/WGA-negative]
nucleoporin 155kDa,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001162$phosphoprotein, 790001266$protein transport, 790001554$translocation, 790001558$transport]
nucleoporin 155kDa,UP_SEQ_FEATURE[850035001$chain:Nuclear pore complex protein Nup155, 850102586$compositionally biased region:Pro-rich, 850105829$glycosylation site:O-linked (GlcNAc), 850106258$modified residue, 850118574$splice variant]
phospholipase A2, group XV,INTERPRO[450002957$IPR003386:Lecithin:cholesterol acyltransferase]
phospholipase A2, group XV,KEGG_PATHWAY[470038778$hsa00564:Glycerophospholipid metabolism, 470038840$hsa04142:Lysosome]
phospholipase A2, group XV,PIR_SUPERFAMILY[630000528$PIRSF000449:phosphatidylcholine-sterol acyltransferase]
phospholipase A2, group XV,SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000356$complete proteome, 790000445$direct protein sequencing, 790000543$fatty acid metabolism, 790000616$glycoprotein, 790000743$hydrolase, 790000873$lipid metabolism, 790000897$lysosome, 790001363$Secreted, 790001405$signal, 790001547$transferase]
phospholipase A2, group XV,UP_SEQ_FEATURE[850000004$active site:Acyl-ester intermediate, 850000011$active site:Charge relay system, 850022445$chain:Group XV phospholipase A2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide]
polycystic kidney disease 1 (autosomal dominant),COG_ONTOLOGY[90000070$Function unknown]
polycystic kidney disease 1 (autosomal dominant),INTERPRO[450000174$IPR000203:GPS, 450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450000513$IPR000601:PKD, 450000897$IPR001024:Lipoxygenase, LH2, 450001149$IPR001304:C-type lectin, 450001429$IPR001611:Leucine-rich repeat, 450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich, 450002529$IPR002859:PKD/REJ-like protein, 450002554$IPR002889:Carbohydrate-binding WSC, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450005655$IPR006228:Polycystin cation channel, 450011765$IPR013122:Polycystin cation channel, PKD1/PKD2, 450012588$IPR013994:Carbohydrate-binding WSC, subgroup, 450012604$IPR014010:Egg jelly receptor, REJ-like, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
polycystic kidney disease 1 (autosomal dominant),OMIM_DISEASE[520004036$Polycystic kidney disease, adult type I]
polycystic kidney disease 1 (autosomal dominant),SMART[760000007$SM00013:LRRNT, 760000026$SM00034:CLECT, 760000071$SM00082:LRRCT, 760000077$SM00089:PKD, 760000166$SM00192:LDLa, 760000273$SM00303:GPS, 760000278$SM00308:LH2, 760000290$SM00321:WSC, 760000333$SM00369:LRR_TYP]
polycystic kidney disease 1 (autosomal dominant),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000848$Lectin, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
polycystic kidney disease 1 (autosomal dominant),UP_SEQ_FEATURE[850039850$chain:Polycystin-1, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850104076$domain:GPS, 850104708$domain:LDL-receptor class A; atypical, 850105003$domain:PKD 1, 850105004$domain:PKD 10, 850105005$domain:PKD 11, 850105006$domain:PKD 12, 850105007$domain:PKD 13, 850105008$domain:PKD 14, 850105009$domain:PKD 15, 850105010$domain:PKD 16, 850105011$domain:PKD 17, 850105012$domain:PKD 2, 850105013$domain:PKD 3, 850105014$domain:PKD 4, 850105015$domain:PKD 5, 850105016$domain:PKD 6, 850105017$domain:PKD 7, 850105018$domain:PKD 8, 850105019$domain:PKD 9, 850105029$domain:PLAT, 850105169$domain:REJ, 850105728$domain:WSC, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850117294$sequence conflict, 850117295$sequence variant, 850117645$short sequence motif:Polycystin motif, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum),INTERPRO[450004592$IPR005123:Oxoglutarate and iron-dependent oxygenase, 450006039$IPR006620:Prolyl 4-hydroxylase, alpha subunit, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1]
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum),SMART[760000609$SM00702:P4Hc]
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000437$dioxygenase, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790001092$oxidoreductase, 790001304$repeat, 790001409$Signal-anchor, 790001555$transmembrane, 790001626$vitamin c]
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum),UP_SEQ_FEATURE[850000176$binding site:2-oxoglutarate, 850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850065973$chain:Transmembrane prolyl 4-hydroxylase, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103759$domain:Fe2OG dioxygenase, 850105770$glycosylation site:N-linked (GlcNAc...), 850106003$metal ion-binding site:Iron, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12,INTERPRO[450000616$IPR000717:Proteasome component region PCI, 450010816$IPR011991:Winged helix repressor DNA-binding]
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12,KEGG_PATHWAY[470038819$hsa03050:Proteasome]
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12,PIR_SUPERFAMILY[630006785$PIRSF006839:26S proteasome non-ATPase regulatory subunit 12]
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12,SMART[760000076$SM00088:PINT]
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001212$polymorphism, 790001254$proteasome, 790001256$protein degradation]
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12,UP_SEQ_FEATURE[850001261$chain:26S proteasome non-ATPase regulatory subunit 12, 850104917$domain:PCI, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
protein phosphatase 2 (formerly 2A), regulatory subunit B'', beta,INTERPRO[450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
protein phosphatase 2 (formerly 2A), regulatory subunit B'', beta,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
protein phosphatase 2 (formerly 2A), regulatory subunit B'', beta,UP_SEQ_FEATURE[850060112$chain:Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta, 850103571$domain:EF-hand, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450001872$IPR002113:Adenine nucleotide translocator 1, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6,PIR_SUPERFAMILY[630002575$PIRSF002458:ADP,ATP carrier protein]
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6,SP_PIR_KEYWORDS[790000012$acetylation, 790000109$Apoptosis, 790000356$complete proteome, 790000445$direct protein sequencing, 790000473$duplication, 790000701$homodimer, 790000733$host-virus interaction, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6,UP_SEQ_FEATURE[850000469$binding site:Nucleotide, 850004063$chain:ADP/ATP translocase 3, 850106258$modified residue, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117294$sequence conflict, 850117295$sequence variant, 850117732$short sequence motif:Substrate recognition, 850118623$transmembrane region]
spectrin, beta, non-erythrocytic 4,INTERPRO[450001411$IPR001589:Actinin-type, actin-binding, conserved site, 450001423$IPR001605:Spectrin/pleckstrin-like, 450001520$IPR001715:Calponin-like actin-binding, 450001635$IPR001849:Pleckstrin homology, 450001788$IPR002017:Spectrin repeat, 450010818$IPR011993:Pleckstrin homology-type, 450014666$IPR016343:Spectrin, beta subunit, 450016451$IPR018159:Spectrin/alpha-actinin]
spectrin, beta, non-erythrocytic 4,PIR_SUPERFAMILY[630002422$PIRSF002297:spectrin, beta subunit, 630002423$PIRSF002297:Spectrin_beta_subunit]
spectrin, beta, non-erythrocytic 4,SMART[760000025$SM00033:CH, 760000132$SM00150:SPEC, 760000205$SM00233:PH]
spectrin, beta, non-erythrocytic 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000018$actin capping, 790000019$actin-binding, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
spectrin, beta, non-erythrocytic 4,UP_SEQ_FEATURE[850061769$chain:Spectrin beta chain, brain 3, 850103007$domain:Actin-binding, 850103318$domain:CH 1, 850103319$domain:CH 2, 850104979$domain:PH, 850106258$modified residue, 850117015$repeat:Spectrin 1, 850117016$repeat:Spectrin 10, 850117017$repeat:Spectrin 11, 850117018$repeat:Spectrin 12, 850117019$repeat:Spectrin 13, 850117020$repeat:Spectrin 14, 850117021$repeat:Spectrin 15, 850117022$repeat:Spectrin 16, 850117023$repeat:Spectrin 17, 850117024$repeat:Spectrin 18, 850117026$repeat:Spectrin 2, 850117037$repeat:Spectrin 3, 850117046$repeat:Spectrin 4, 850117047$repeat:Spectrin 5, 850117048$repeat:Spectrin 6, 850117049$repeat:Spectrin 7, 850117050$repeat:Spectrin 8, 850117051$repeat:Spectrin 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
speedy homolog C (Xenopus laevis),KEGG_PATHWAY[470038835$hsa04114:Oocyte meiosis, 470038884$hsa04914:Progesterone-mediated oocyte maturation]
speedy homolog C (Xenopus laevis),SP_PIR_KEYWORDS[790000258$cell cycle, 790000356$complete proteome, 790001065$nucleus]
speedy homolog C (Xenopus laevis),UP_SEQ_FEATURE[850061776$chain:Speedy protein C, 850114687$region of interest:Speedy/Ringo box; required for cdk- binding]
splicing factor, arginine/serine-rich 12,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
splicing factor, arginine/serine-rich 12,PIR_SUPERFAMILY[630029690$PIRSF038101:Splicing factor, arginine/serine-rich 12]
splicing factor, arginine/serine-rich 12,SMART[760000328$SM00360:RRM]
splicing factor, arginine/serine-rich 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001433$Spliceosome]
splicing factor, arginine/serine-rich 12,UP_SEQ_FEATURE[850062066$chain:Splicing factor, arginine/serine-rich 12, 850102423$compositionally biased region:Arg/Glu/Lys/Ser-rich, 850105211$domain:RRM, 850106258$modified residue, 850118574$splice variant]
stromal interaction molecule 1,INTERPRO[450001470$IPR001660:Sterile alpha motif SAM, 450010372$IPR011510:Sterile alpha motif homology 2, 450016532$IPR018247:EF-HAND 1]
stromal interaction molecule 1,OMIM_DISEASE[520002608$Immune dysfunction, with T-cell inactivation due to calcium entry defect 2]
stromal interaction molecule 1,SMART[760000399$SM00454:SAM]
stromal interaction molecule 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000215$calcium transport, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane, 790001558$transport]
stromal interaction molecule 1,UP_SEQ_FEATURE[850062579$chain:Stromal interaction molecule 1, 850102507$compositionally biased region:Glu-rich, 850102554$compositionally biased region:Lys-rich, 850102592$compositionally biased region:Pro/Ser-rich, 850103571$domain:EF-hand, 850105249$domain:SAM, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
tripartite motif-containing 31,INTERPRO[450000269$IPR000315:Zinc finger, B-box, 450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
tripartite motif-containing 31,SMART[760000158$SM00184:RING, 760000304$SM00336:BBOX]
tripartite motif-containing 31,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000859$ligase, 790000937$metal-binding, 790000969$mitochondrion, 790001212$polymorphism, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
tripartite motif-containing 31,UP_SEQ_FEATURE[850016765$chain:E3 ubiquitin-protein ligase TRIM31, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118638$zinc finger region:B box-type, 850118911$zinc finger region:RING-type]
ubiquitin D,INTERPRO[450000534$IPR000626:Ubiquitin, 450018186$IPR019956:Ubiquitin subgroup]
ubiquitin D,SMART[760000186$SM00213:UBQ]
ubiquitin D,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway]
ubiquitin D,UP_SEQ_FEATURE[850068028$chain:Ubiquitin D, 850106258$modified residue, 850114993$region of interest:Ubiquitin 1, 850114994$region of interest:Ubiquitin 2, 850117295$sequence variant]
unkempt homolog (Drosophila)-like,INTERPRO[450000486$IPR000571:Zinc finger, CCCH-type, 450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
unkempt homolog (Drosophila)-like,SMART[760000158$SM00184:RING, 760000324$SM00356:ZnF_C3H1]
unkempt homolog (Drosophila)-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
unkempt homolog (Drosophila)-like,UP_SEQ_FEATURE[850058236$chain:RING finger protein unkempt-like, 850102597$compositionally biased region:Ser-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118911$zinc finger region:RING-type]
zinc finger and BTB domain containing 12,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger and BTB domain containing 12,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006475$IPR007087:Zinc finger, C2H2-type, 450010229$IPR011333:BTB/POZ fold, 450011722$IPR013069:BTB/POZ, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger and BTB domain containing 12,PIR_SUPERFAMILY[630029438$PIRSF037869:Zinc finger and BTB domain-containing protein]
zinc finger and BTB domain containing 12,SMART[760000197$SM00225:BTB, 760000323$SM00355:ZnF_C2H2]
zinc finger and BTB domain containing 12,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger and BTB domain containing 12,UP_SEQ_FEATURE[850101228$chain:Zinc finger and BTB domain-containing protein 12, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850103177$domain:BTB, 850106258$modified residue, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4]
zinc finger, CCHC domain containing 6,COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
zinc finger, CCHC domain containing 6,INTERPRO[450001661$IPR001878:Zinc finger, CCHC-type, 450001823$IPR002058:PAP/25A-associated, 450002588$IPR002934:Nucleotidyltransferase, 450006475$IPR007087:Zinc finger, C2H2-type]
zinc finger, CCHC domain containing 6,SMART[760000311$SM00343:ZnF_C2HC]
zinc finger, CCHC domain containing 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001064$nucleotidyltransferase, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
zinc finger, CCHC domain containing 6,UP_SEQ_FEATURE[850063846$chain:Terminal uridylyltransferase 7, 850102507$compositionally biased region:Glu-rich, 850102566$compositionally biased region:Poly-Arg, 850102568$compositionally biased region:Poly-Asp, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118777$zinc finger region:CCHC-type 1, 850118779$zinc finger region:CCHC-type 2, 850118781$zinc finger region:CCHC-type 3]
